
Arixone S 1000mg/500mg Injection
Marketer
Arion Healthcare
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Arixone S 1000mg/500mg Injection
Combiflox, a dual-action injectable formulation (1000mg/500mg), combats diverse bacterial infections by inhibiting microbial proliferation and propagation. Administration must be strictly under medical guidance. Complete the prescribed regimen, even with symptom improvement; premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; severe reactions warrant immediate medical attention. Allergic responses (rash, pruritus, edema, dyspnea) require prompt emergency care. Inform your physician about concurrent medications, and pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Monitoring via laboratory tests may be employed to assess therapeutic response.
Primary Ingredients of Arixone S 1000mg/500mg Injection
No text provided to rephrase.
Uses of Arixone S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Arixone S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Arixone S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Arixone S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Arixone S 1000mg/500mg Injection works:
Arixone S Injection (1000mg/500mg) combines the antibiotic ceftriaxone with the beta-lactamase inhibitor sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counters bacterial resistance, thereby boosting ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Arixone S 1000mg/500mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Arixone S (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal to no negative impacts on fetal development; clinical data from human studies, however, remain scarce.
Breast feedingCAUTION
The administration of Arixone S 1000mg/500mg Injection necessitates careful consideration during lactation. Mothers should temporarily discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Arixone S 1000mg/500mg Injection can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Arixone S 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use the Arixone S 1000mg/500mg Injection cautiously, as dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Arixone S 1000mg/500mg Injection is not advised for individuals with mild to moderate liver dysfunction.
What if you forget to take Arixone S 1000mg/500mg Injection :
Should you forget a scheduled Arixone S 1000mg/500mg Injection, seek advice from your physician.
Facts to Know About Arixone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobials |
